Blue Trust Inc
ATHE icon

Blue Trust Inc’s Alterity Therapeutics ATHE Stock Holding History

Blue Trust Inc’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$146 Hold
40
– – ﹤0.01% 2398
2026
Q2 		$215 Hold
40
– – ﹤0.01% 2392
2026
Q1 		$139 Hold
40
– – ﹤0.01% 2436
2025
Q4 		$123 Hold
40
– – ﹤0.01% 2495
2025
Q3 		$150 Hold
40
– – ﹤0.01% 2523
2025
Q2 		$164 Hold
40
– – ﹤0.01% 2391
2025
Q1 		$138 Hold
40
– – ﹤0.01% 2437
2024
Q4 		$132 Hold
40
– – ﹤0.01% 2395
2024
Q3 		$72 Buy
+40
New +$59 ﹤0.01% 2880

Other funds holding ATHE

Greenleaf Trust
Greenleaf Trust Kalamazoo, Michigan $9.8B AUM 2.94% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Cranbrook Wealth Management
Cranbrook Wealth Management Bloomfield Hills, Michigan $529M AUM 11.19% 1-Year Est. Return

Blue Trust Inc's ATHE Position: Q3 2026 in Review

Blue Trust Inc held its Alterity Therapeutics (ATHE) position steady in Q3 2026 at 40 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

Blue Trust Inc first reported a position in ATHE in Q3 2024 and has held it in 9 quarters since. The position peaked at $215 in Q2 2026. 12 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.

  • Blue Trust Inc held 40 shares of Alterity Therapeutics worth $146 as of Q3 2026.
  • Blue Trust Inc left its Alterity Therapeutics share count unchanged in Q3 2026.
  • Alterity Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2398 holding.
  • Blue Trust Inc first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • Blue Trust Inc's Alterity Therapeutics position peaked at $215 in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.